Skip to Content
Upcoming Webinar

Managing KOMZIFTI in Patients With Relapsed/Refractory NPM1‑mutated AML

Date: December 11, 2025 | 2:00 PM
When: Thursday, December 11 | 2 p.m. & 5 p.m. EST
Presenters:
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC | Minnesota Oncology

Treating R/R NPM1-mutated AML comes with plenty of clinical and operational questions — and this webinar is designed to make the path clearer. Dr. Kirollos Hanna will break down the evidence and the practical steps needed to manage KOMZIFTI confidently in your practice.

Topics include:

  • Understanding and identifying R/R NPM1-m AML
  • KOMZIFTI trial design and clinical data
  • Treatment considerations
  • Dosing
  • Prescription fulfillment
  • Patient Assistance

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.